Literature DB >> 20962557

[Risk factors for development and recurrence of peptic ulcer disease].

Jin Joo Kim1, Nayoung Kim, Byoung Hwan Lee, Jung Mook Kang, Pyoungju Seo, Min Kyoung Lim, Jung Hee Kwon, Byeong Jun Song, Jung Won Lee, Sang Hyup Lee, Young Soo Park, Jin Hyeok Hwang, Jin Wook Kim, Sook Hyang Jeong, Dong Ho Lee, Hyun Chae Jung, In Sung Song.   

Abstract

BACKGROUND/AIMS: Peptic ulcer disease (PUD) is one of the common gastrointestinal diseases, and its medical management has been developed so much that the incidence of its serious complications, such as bleeding and perforation, are declining significantly. Its prevalence in Korea is not definitely decreased, probably due to increasing proportion of elderly patients and their rising usage of non-steroidal anti-inflammatory drugs (NSAIDs) and aspirin. This study was conducted to identify the risk factors for development and recurrence of peptic ulcer disease in Korea.
METHODS: From 2003 to 2008, upper gastrointestinal endoscopy and detailed personal questionnaires were performed for patients who visited Department of Gastroenterology at Seoul National University Bundang Hospital. In total, 475 PUD patients and 335 non-ulcer dyspepsia patients were included. The results of questionnaires and repeated upper gastrointestinal endoscopy at initial diagnosis time and follow-up periods were analyzed.
RESULTS: Multivariable analysis showed that male, H. pylori infection, NSAIDs use and smoking were risk factors for the development of PUD. The use of proton pump inhibitors (PPIs) and H2 receptor antagonists has significantly reduced the risk of PUD in patients who had taken NSAIDs and/or aspirin. H. pylori infection was found as the only risk factor for the recurrence of PUD.
CONCLUSIONS: For the old patients who are taking drugs, such as NSAIDs and aspirin, concomitant use of PPIs or H2 receptor antagonists should be considered to protect from the development of PUD. H. pylori eradication has been confirmed again to be essential for the treatment of PUD patients infected with H. pylori.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20962557     DOI: 10.4166/kjg.2010.56.4.220

Source DB:  PubMed          Journal:  Korean J Gastroenterol        ISSN: 1598-9992


  5 in total

1.  The burden of smoking in Israel-attributable mortality and costs (2014).

Authors:  Gary M Ginsberg; Haim Geva
Journal:  Isr J Health Policy Res       Date:  2014-08-29

2.  Clinical characteristics of peptic ulcer perforation in Korea.

Authors:  Young Joo Yang; Chang Seok Bang; Suk Pyo Shin; Tae Young Park; Ki Tae Suk; Gwang Ho Baik; Dong Joon Kim
Journal:  World J Gastroenterol       Date:  2017-04-14       Impact factor: 5.742

3.  The efficacy and safety of irsogladine maleate in nonsteroidal anti-inflammatory drug or aspirin-induced peptic ulcer and gastritis.

Authors:  Ki-Nam Shim; Jin Il Kim; Nayoung Kim; Sang Gyun Kim; Yun Ju Jo; Su Jin Hong; Jeong Eun Shin; Gwang Ha Kim; Kyung Sik Park; Suck Chei Choi; Joong Goo Kwon; Jie-Hyun Kim; Hyun Jin Kim; Ji Won Kim
Journal:  Korean J Intern Med       Date:  2018-06-01       Impact factor: 2.884

4.  There Is No Reason to Delay Helicobacter pylori Eradication after Treatment for Upper Gastrointestinal Bleeding.

Authors:  Sun-Young Lee
Journal:  Gut Liver       Date:  2015-05-23       Impact factor: 4.519

5.  Long-Term Recurrence Rates of Peptic Ulcers without Helicobacter pylori.

Authors:  Jae Hyun Seo; Su Jin Hong; Jie-Hyun Kim; Byung-Wook Kim; Sam Ryong Jee; Woo Chul Chung; Ki-Nam Shim; Gwang Ho Baik; Sung Soo Kim; Sang Gyun Kim; Jin Il Kim
Journal:  Gut Liver       Date:  2016-09-15       Impact factor: 4.519

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.